ANAPLASTIC OLIGODENDROGLIOMA
Clinical trials for ANAPLASTIC OLIGODENDROGLIOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC OLIGODENDROGLIOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC OLIGODENDROGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug ruxolitinib joins standard therapy in brain cancer battle
Disease control CompletedThis early-phase study tested whether adding the experimental drug ruxolitinib to standard radiation and chemotherapy (temozolomide) is safe for people with newly diagnosed high-grade gliomas or glioblastoma. Ruxolitinib targets proteins that help cancer cells grow. The study enr…
Matched conditions: ANAPLASTIC OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New chemo cocktail shows promise for rare brain tumor patients
Disease control CompletedThis study tested a combination of two chemotherapy drugs (BCNU and TMZ) given before radiation therapy in 53 people newly diagnosed with a rare type of brain cancer called anaplastic oligodendroglioma. The goal was to see how well the drugs shrank tumors and to learn more about …
Matched conditions: ANAPLASTIC OLIGODENDROGLIOMA
Phase: PHASE2 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug shows promise in early trial for kids with deadly brain cancer
Disease control CompletedThis early-phase study tested an experimental drug called INCB7839 in 13 children whose high-grade gliomas (aggressive brain tumors) had come back or worsened after standard treatment. The main goals were to find a safe dose and check for side effects. The drug works by blocking …
Matched conditions: ANAPLASTIC OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: Pediatric Brain Tumor Consortium • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Simple blood test could help monitor aggressive brain tumors
Knowledge-focused CompletedThis study looked at whether a blood test measuring a protein called hPG80 (progastrin) can help track high-grade brain tumors like glioblastoma. Researchers took blood samples from 30 patients before, during, and after radiation and chemotherapy. The goal was to see if hPG80 lev…
Matched conditions: ANAPLASTIC OLIGODENDROGLIOMA
Sponsor: Centre Jean Perrin • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC